Realcan Pharmaceutical Group Co., Ltd. (002589.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.17B
Enterprise Value7.92B
P/E Ratio500
PEG Ratio-1.37
Price/Sales Ratio0.57
Price/Book Ratio0.84
Enterprise/Revenue0.92
Enterprise/EBITDA23.52

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue7.3B
Revenue/Share4.88
Gross Profit776.06M
EBITDA360.68M
Net Income16.07M
Diluted EPS0.01

Balance Sheet

Total Cash5.75B
Total Cash/Share3.91
Total Debt8.28B
Total Debt/Equity1.56
Current Ratio1.08
Book Value Per Share3.71

Price History

52-Week Change3.74
52-Week High4.69
52-Week Low2.38
Moving Average 50 Days3.01
Moving Average 200 Days3.17

Statistics

Average Volume82.27M
Shares Outstanding1.33B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0.07
Payout Ratio7.18
Last Split Factor23:10
Last Split DateMay 15, 2017
AD